Retroperitoneal Laparoscopic Surgery in the Treatment of Complex Adrenal Tumors.

complex adrenal tumor laparoscopy retroperitoneal approach surgery

Journal

Cancer management and research
ISSN: 1179-1322
Titre abrégé: Cancer Manag Res
Pays: New Zealand
ID NLM: 101512700

Informations de publication

Date de publication:
2020
Historique:
received: 08 04 2020
accepted: 26 06 2020
entrez: 9 8 2020
pubmed: 9 8 2020
medline: 9 8 2020
Statut: epublish

Résumé

To explore the laparoscopic technique with the retroperitoneal approach for complex adrenal tumors. The clinical data of 11 patients with complex adrenal tumors from July 2017 to July 2018 were analyzed retrospectively. Among them, there were 4 males and 7 females, 4 with adrenal myelolipomas, 3 with adrenal pheochromocytomas, 2 with adrenal cysts, 1 with adrenocortical adenoma and 1 with adrenal ganglioneuroma. The average tumor diameter was 6.5 ± 1.2 cm, and the average age of the patients was 48 ± 13 years. All the operations were successfully completed. The average operation time was 95 ± 15 min, the average amount of blood loss was 50 ± 15 mL, and the average postoperative hospital stay was 2.6 ± 1.3 days. No tumor recurrence was found after 1 year of follow-up. Retroperitoneal laparoscopic surgery is effective for the treatment of complex adrenal tumors, but it requires good surgical skills. Surgeons skilled in laparoscopic technology can safely carry out retroperitoneal laparoscopic surgery for complex adrenal tumors.

Identifiants

pubmed: 32765081
doi: 10.2147/CMAR.S257310
pii: 257310
pmc: PMC7368566
doi:

Types de publication

Journal Article

Langues

eng

Pagination

5787-5791

Informations de copyright

© 2020 Huang et al.

Déclaration de conflit d'intérêts

The authors report no funding and no conflicts of interest for this work.

Références

World J Surg Oncol. 2019 Jun 29;17(1):111
pubmed: 31253139
J Laparoendosc Adv Surg Tech A. 2016 Jun;26(6):453-6
pubmed: 27128147
J Cardiothorac Vasc Anesth. 2017 Aug;31(4):1427-1439
pubmed: 28392094
Gland Surg. 2019 Apr;8(2):115-122
pubmed: 31183321
J Minim Access Surg. 2014 Apr;10(2):57-61
pubmed: 24761076
J Surg Oncol. 2018 Sep;118(4):709-715
pubmed: 30175399
Curr Opin Oncol. 2020 Jan;32(1):27-34
pubmed: 31644473
N Engl J Med. 1992 Oct 1;327(14):1033
pubmed: 1387700
Minerva Chir. 2014 Apr;69(2):59-64
pubmed: 24847892
Endocr Regul. 2017 Jul 1;51(3):168-181
pubmed: 28858847
J Endourol. 2016 Mar;30(3):306-11
pubmed: 26486758
Surgery. 2019 Mar;165(3):637-643
pubmed: 30482519

Auteurs

Kai Huang (K)

Department of Urology, College of Clinical Medicine, Yangzhou University, Northern Jiangsu People's Hospital, Yangzhou, Jiangsu Province, People's Republic of China.

Yehua Wang (Y)

Department of Urology, College of Clinical Medicine, Yangzhou University, Northern Jiangsu People's Hospital, Yangzhou, Jiangsu Province, People's Republic of China.

Xiao Gu (X)

Department of Urology, College of Clinical Medicine, Yangzhou University, Northern Jiangsu People's Hospital, Yangzhou, Jiangsu Province, People's Republic of China.

Qin Xiao (Q)

Department of Pathology, College of Clinical Medicine, Yangzhou University, Northern Jiangsu People's Hospital, Yangzhou, Jiangsu Province, People's Republic of China.

Xiangan Tu (X)

Department of Urology and Andrology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong Province, People's Republic of China.

Classifications MeSH